Company is almost debt free.
Company has delivered good profit growth of 35.0% CAGR over last 5 years
PE of 8 vs Industry PE of 29
Dividend Yield 1.12 %
ROCE 17 %
ROE 12.2 %
Albert David Ltd is engaged in manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
During FY22, the Co. introduced two products i.e., Evacure and C3H in the market. It is expected that these two products will augment the revenue and profits of the Company.
Company has delivered good profit growth of 35.0% CAGR over last 5 years
PE of 8 vs Industry PE of 29
Dividend Yield 1.12 %
ROCE 17 %
ROE 12.2 %
Albert David Ltd is engaged in manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
During FY22, the Co. introduced two products i.e., Evacure and C3H in the market. It is expected that these two products will augment the revenue and profits of the Company.
*DISCLAIMER*
For educational purposes only. Not a recommendation.
Treat StopLoss as your best friend to get you out of troubles.
For educational purposes only. Not a recommendation.
Treat StopLoss as your best friend to get you out of troubles.